Heat Shock Protein 90 and Role of Its Chemical Inhibitors in Treatment of Hematologic Malignancies
Heat shock protein 90 (Hsp90) is a conserved and constitutively expressed molecular chaperone and it has been shown to stabilize oncoproteins and facilitate cancer development. Hsp90 has been considered as a therapeutic target for cancers and three classes of Hsp90 inhibitors have been developed: (1...
Saved in:
Main Authors: | Haojian Zhang (Author), Adam Li (Author), Shaoguang Li (Author), Ngoc Ho (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2012-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery and development of natural heat shock protein 90 inhibitors in cancer treatment
by: Yong Li, et al.
Published: (2012) -
Heat Shock Protein 90 c-Terminal Inhibitors in Cancer Treatment
by: Yusuf Tutar
Published: (2015) -
Heat Shock Protein 90 (Hsp90) Expression and Breast Cancer
by: Christos A. Papadimitriou, et al.
Published: (2012) -
Effects of Heat Shock Protein 90 Inhibition In the Lungs
by: Mohammad A. Uddin, et al.
Published: (2020) -
Target-Mediated Brain Tissue Binding for Small Molecule Inhibitors of Heat Shock Protein 90
by: Lassina Badolo, et al.
Published: (2020)